SAB Biotherapeutics Inc SABS
News
SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
SAB BIO to Participate in Upcoming Investor Conferences
